For the second consecutive year BNP Paribas Corporate & Investment Banking (CIB) has involved itself in a charitable and global cause.
The budget normally reserved for year-end business gifts is being donated to the Institut Pasteur for the global fight against infectious diseases.

In 2009, BNP Paribas CIB again brings its financial support to the Institut Pasteur’s international network of research teams as well as other laboratories working with the Institut Pasteur in Paris and in 26 other countries. The Institut Pasteur is involved in various issues in regards to diseases: hepatitis C (Japan), vaccine against the measles and HIV (United Kingdom), malaria (Colombia, Brazil), the West Nile Virus (Czech Republic), tuberculosis (The Netherlands), influenza viruses (France, Hong-Kong, Greece) … In France, BNP Paribas CIB supports the medical research on the resistance of respiratory influenza viruses H5N1 and H1N1, as part of a project partly financed by the European Union

“The international dimension of our partnership with the Institut Pasteur, the criteria of excellence, innovation and quality attached to projects supported in each country, are very similar to our own values,” stated Alain Papiasse, Head of BNP Paribas CIB. “That is why we are proud to again, bring our support this year to such projects and thus help advance medical research. As a large international company, we believe that this commitment is an integral part of our natural field of citizenship. “